Panavir® (Panavir®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substancePolysaccharides of shoots Solanum tuberosumPolysaccharides of shoots Solanum tuberosum
Similar drugsTo uncover
  • Panavir®
    suppositories rect. 
    NATIONAL RESEARCH COMPANY, LTD.     Russia
  • Panavir®
    gel locally externally 
    NATIONAL RESEARCH COMPANY, LTD.     Russia
  • Panavir®
    suppositories the vagina. 
    NATIONAL RESEARCH COMPANY, LTD.     Russia
  • Panavir®
    solution in / in 
    NATIONAL RESEARCH COMPANY, LTD.     Russia
    • Dosage form: & nbspVaginal suppositories
    Composition:

    1 suppository contains:

    active substance: Panavir® (polysaccharides of shoots Solarium tuberosum) 0.0002 g;

    Excipients: polyethylene oxide 1500 (macrogol 1500) 1.2599 g, polyethylene oxide 400 (macrogol-400) 0.1399 g

    Description:

    Suppositories cylindrical or cone-shaped, grayish-white, translucent.

    Pharmacotherapeutic group:antiviral agent of plant origin
    ATX: & nbsp

    J.05.A.X   Other antiviral drugs

    Pharmacodynamics:

    The main active ingredient is hexose glycoside, consisting of glucose, rhamnose, arabinose, mannose, xylose, galactose, uronic acids

    The drug Panavir® is an antiviral and immunomodulating agent. Has antiviral action against herpes simplex virus type 1 and type 2.

    Increases nonspecific resistance of the organism to various infections and promotes the induction of interferons.

    Pharmacokinetics:

    Pharmacokinetics of the drug has not been studied in connection with its chemical nature and small acting doses.

    Indications:

    Genital herpes in women (in complex therapy).

    Contraindications:Hypersensitivity to the components of the drug, severe kidney and spleen diseases, pregnancy, lactation, age under 18 years.
    Dosing and Administration:

    Intravaginal.

    Vaginal suppositories are administered in the evening in the vagina, as deep as possible, in the supine position with slightly bent legs, daily for 5 days for 1 vaginal suppository.

    A second course of treatment is possible after consulting a doctor.

    Side effects:

    In rare cases, allergic reactions are possible.

    However, if there are any undesirable side effects, stop using the drug and consult a doctor.

    If you notice any other side effects not listed in the instructions, tell your doctor.

    Overdose:

    Cases of overdose are not registered.

    Interaction:Not registered.
    Special instructions:

    To prevent urogenital reinfection, simultaneous treatment of sexual partners is necessary.

    If there is no effect, you must confirm the diagnosis.

    Effect on the ability to drive transp. cf. and fur:

    The use of the drug does not affect the management of vehicles and occupations of other potentially hazardous activities requiring increased concentration of attention and speed of psychomotor reactions.

    Form release / dosage:

    Vaginal suppositories 200 mcg.

    Packaging:

    For 5 suppositories in a contiguous cell package, 1 contour pack together with instructions for use in a pack of cardboard.

    Storage conditions:

    In a dry, dark place at a temperature of 2 ° C to 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use after expiry date.

    Terms of leave from pharmacies:On prescription
    Registration number:LP-001278
    Date of registration:25.11.2011
    The owner of the registration certificate:NATIONAL RESEARCH COMPANY, LTD. NATIONAL RESEARCH COMPANY, LTD. Russia
    Manufacturer: & nbsp
    Information update date: & nbsp26.08.2015
    Illustrated instructions
      Instructions
      Up